Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 487 entries
Sorted by: Best Match Show Resources per page
Magnetic resonance imaging. National Institutes of Health Consensus Development Conference statement.

Oncology (Williston Park, N.Y.)

[No authors listed]
PMID: 3275044
Oncology (Williston Park). 1988 Nov;2(11):53-5, 58-9, 62-3 passim.

No abstract available.

Cite
Magnetic resonance imaging. National Institutes of Health Consensus Development Conference statement. Oncology (Williston Park). 1988;2(11):53-5, 58-9, 62-3 passim
(1988). Magnetic resonance imaging. National Institutes of Health Consensus Development Conference statement. Oncology (Williston Park, N.Y.), 2(11), 53-5, 58-9, 62-3 passim.
"Magnetic resonance imaging. National Institutes of Health Consensus Development Conference statement." Oncology (Williston Park, N.Y.) vol. 2,11 (1988): 53-5, 58-9, 62-3 passim.
Magnetic resonance imaging. National Institutes of Health Consensus Development Conference statement. Oncology (Williston Park). 1988 Nov;2(11):53-5, 58-9, 62-3 passim. PMID: 3275044.
Copy Download .nbib Format: NLM
Commentary (Pollock): Radiation Therapy in the Management of Brain Metastases From Renal Cell Carcinoma.

Oncology (Williston Park, N.Y.)

Pollock BE.
PMID: 28326510
Oncology (Williston Park). 2006 May 01;20(6).

No abstract available.

Cite
Pollock BE. Commentary (Pollock): Radiation Therapy in the Management of Brain Metastases From Renal Cell Carcinoma. Oncology (Williston Park). 2006;20(6)
Pollock, B. E. (2006). Commentary (Pollock): Radiation Therapy in the Management of Brain Metastases From Renal Cell Carcinoma. Oncology (Williston Park, N.Y.), 20(6), .
Pollock, Bruce E. "Commentary (Pollock): Radiation Therapy in the Management of Brain Metastases From Renal Cell Carcinoma." Oncology (Williston Park, N.Y.) vol. 20,6 (2006).
Pollock BE. Commentary (Pollock): Radiation Therapy in the Management of Brain Metastases From Renal Cell Carcinoma. Oncology (Williston Park). 2006 May 01;20(6). PMID: 28326510.
Copy Download .nbib Format: NLM
(S018) intensity-modulated radiation therapy or conformal radiation therapy and cardiopulmonary mortality risk in the elderly with esophageal cancer.

Oncology (Williston Park, N.Y.)

[No authors listed]
PMID: 25930747
Oncology (Williston Park). 2015 Apr 21;29(4).

No abstract available.

Cite
(S018) intensity-modulated radiation therapy or conformal radiation therapy and cardiopulmonary mortality risk in the elderly with esophageal cancer. Oncology (Williston Park). 2015;29(4)
(2015). (S018) intensity-modulated radiation therapy or conformal radiation therapy and cardiopulmonary mortality risk in the elderly with esophageal cancer. Oncology (Williston Park, N.Y.), 29(4), .
"(S018) intensity-modulated radiation therapy or conformal radiation therapy and cardiopulmonary mortality risk in the elderly with esophageal cancer." Oncology (Williston Park, N.Y.) vol. 29,4 (2015).
(S018) intensity-modulated radiation therapy or conformal radiation therapy and cardiopulmonary mortality risk in the elderly with esophageal cancer. Oncology (Williston Park). 2015 Apr 21;29(4). PMID: 25930747.
Copy Download .nbib Format: NLM
(S037) Phenotypic Diversity Measured in PET/CT Scans Predicts Overall Survival in Early-Stage Lung Adenocarcinoma.

Oncology (Williston Park, N.Y.)

[No authors listed]
PMID: 25930752
Oncology (Williston Park). 2015 Apr 21;29(4).

No abstract available.

Cite
(S037) Phenotypic Diversity Measured in PET/CT Scans Predicts Overall Survival in Early-Stage Lung Adenocarcinoma. Oncology (Williston Park). 2015;29(4)
(2015). (S037) Phenotypic Diversity Measured in PET/CT Scans Predicts Overall Survival in Early-Stage Lung Adenocarcinoma. Oncology (Williston Park, N.Y.), 29(4), .
"(S037) Phenotypic Diversity Measured in PET/CT Scans Predicts Overall Survival in Early-Stage Lung Adenocarcinoma." Oncology (Williston Park, N.Y.) vol. 29,4 (2015).
(S037) Phenotypic Diversity Measured in PET/CT Scans Predicts Overall Survival in Early-Stage Lung Adenocarcinoma. Oncology (Williston Park). 2015 Apr 21;29(4). PMID: 25930752.
Copy Download .nbib Format: NLM
(P011) Stereotactic Radiosurgery and BRAF Inhibitor Therapy for Melanoma Brain Metastases Is Associated With Increased Risk for Radiation Necrosis.

Oncology (Williston Park, N.Y.)

[No authors listed]
PMID: 25930817
Oncology (Williston Park). 2015 Apr 21;29(4).

No abstract available.

Cite
(P011) Stereotactic Radiosurgery and BRAF Inhibitor Therapy for Melanoma Brain Metastases Is Associated With Increased Risk for Radiation Necrosis. Oncology (Williston Park). 2015;29(4)
(2015). (P011) Stereotactic Radiosurgery and BRAF Inhibitor Therapy for Melanoma Brain Metastases Is Associated With Increased Risk for Radiation Necrosis. Oncology (Williston Park, N.Y.), 29(4), .
"(P011) Stereotactic Radiosurgery and BRAF Inhibitor Therapy for Melanoma Brain Metastases Is Associated With Increased Risk for Radiation Necrosis." Oncology (Williston Park, N.Y.) vol. 29,4 (2015).
(P011) Stereotactic Radiosurgery and BRAF Inhibitor Therapy for Melanoma Brain Metastases Is Associated With Increased Risk for Radiation Necrosis. Oncology (Williston Park). 2015 Apr 21;29(4). PMID: 25930817.
Copy Download .nbib Format: NLM
(P015) Radiation Biological Responses of MRI-Linac vs Linac in Human Head and Neck and Lung Cancer Cells.

Oncology (Williston Park, N.Y.)

[No authors listed]
PMID: 25930824
Oncology (Williston Park). 2015 Apr 21;29(4).

No abstract available.

Cite
(P015) Radiation Biological Responses of MRI-Linac vs Linac in Human Head and Neck and Lung Cancer Cells. Oncology (Williston Park). 2015;29(4)
(2015). (P015) Radiation Biological Responses of MRI-Linac vs Linac in Human Head and Neck and Lung Cancer Cells. Oncology (Williston Park, N.Y.), 29(4), .
"(P015) Radiation Biological Responses of MRI-Linac vs Linac in Human Head and Neck and Lung Cancer Cells." Oncology (Williston Park, N.Y.) vol. 29,4 (2015).
(P015) Radiation Biological Responses of MRI-Linac vs Linac in Human Head and Neck and Lung Cancer Cells. Oncology (Williston Park). 2015 Apr 21;29(4). PMID: 25930824.
Copy Download .nbib Format: NLM
(P016) The Cell Cycle Inhibitor P21 Regulates Langerhans Cell Radiation Resistance and PromotesT Regulatory Cell Induction Upon Exposure to Radiotherapy.

Oncology (Williston Park, N.Y.)

[No authors listed]
PMID: 25930825
Oncology (Williston Park). 2015 Apr 21;29(4).

No abstract available.

Cite
(P016) The Cell Cycle Inhibitor P21 Regulates Langerhans Cell Radiation Resistance and PromotesT Regulatory Cell Induction Upon Exposure to Radiotherapy. Oncology (Williston Park). 2015;29(4)
(2015). (P016) The Cell Cycle Inhibitor P21 Regulates Langerhans Cell Radiation Resistance and PromotesT Regulatory Cell Induction Upon Exposure to Radiotherapy. Oncology (Williston Park, N.Y.), 29(4), .
"(P016) The Cell Cycle Inhibitor P21 Regulates Langerhans Cell Radiation Resistance and PromotesT Regulatory Cell Induction Upon Exposure to Radiotherapy." Oncology (Williston Park, N.Y.) vol. 29,4 (2015).
(P016) The Cell Cycle Inhibitor P21 Regulates Langerhans Cell Radiation Resistance and PromotesT Regulatory Cell Induction Upon Exposure to Radiotherapy. Oncology (Williston Park). 2015 Apr 21;29(4). PMID: 25930825.
Copy Download .nbib Format: NLM
(P062) Comparison of Stereotactic Body Radiotherapy (SBRT) and Conventional External Beam Radiotherapy (EBRT) in Renal Cell Carcinoma (RCC).

Oncology (Williston Park, N.Y.)

[No authors listed]
PMID: 25930831
Oncology (Williston Park). 2015 Apr 21;29(4).

No abstract available.

Cite
(P062) Comparison of Stereotactic Body Radiotherapy (SBRT) and Conventional External Beam Radiotherapy (EBRT) in Renal Cell Carcinoma (RCC). Oncology (Williston Park). 2015;29(4)
(2015). (P062) Comparison of Stereotactic Body Radiotherapy (SBRT) and Conventional External Beam Radiotherapy (EBRT) in Renal Cell Carcinoma (RCC). Oncology (Williston Park, N.Y.), 29(4), .
"(P062) Comparison of Stereotactic Body Radiotherapy (SBRT) and Conventional External Beam Radiotherapy (EBRT) in Renal Cell Carcinoma (RCC)." Oncology (Williston Park, N.Y.) vol. 29,4 (2015).
(P062) Comparison of Stereotactic Body Radiotherapy (SBRT) and Conventional External Beam Radiotherapy (EBRT) in Renal Cell Carcinoma (RCC). Oncology (Williston Park). 2015 Apr 21;29(4). PMID: 25930831.
Copy Download .nbib Format: NLM
(P096) Late Radiation-Associated Dysphagia (Late-RAD) With Lower Cranial Neuropathy After Oropharyngeal IMRT.

Oncology (Williston Park, N.Y.)

[No authors listed]
PMID: 25930837
Oncology (Williston Park). 2015 Apr 21;29(4).

No abstract available.

Cite
(P096) Late Radiation-Associated Dysphagia (Late-RAD) With Lower Cranial Neuropathy After Oropharyngeal IMRT. Oncology (Williston Park). 2015;29(4)
(2015). (P096) Late Radiation-Associated Dysphagia (Late-RAD) With Lower Cranial Neuropathy After Oropharyngeal IMRT. Oncology (Williston Park, N.Y.), 29(4), .
"(P096) Late Radiation-Associated Dysphagia (Late-RAD) With Lower Cranial Neuropathy After Oropharyngeal IMRT." Oncology (Williston Park, N.Y.) vol. 29,4 (2015).
(P096) Late Radiation-Associated Dysphagia (Late-RAD) With Lower Cranial Neuropathy After Oropharyngeal IMRT. Oncology (Williston Park). 2015 Apr 21;29(4). PMID: 25930837.
Copy Download .nbib Format: NLM
(P077) Defining the Pendulum Swing From Whole-Pelvic Radiation Therapy (WPRT) Alone to Vaginal Brachytherapy (VB) in the Adjuvant Setting for Endometrial Cancer: A SEER-Based Analysis From Years 2000-2011.

Oncology (Williston Park, N.Y.)

[No authors listed]
PMID: 25930848
Oncology (Williston Park). 2015 Apr 21;29(4).

No abstract available.

Cite
(P077) Defining the Pendulum Swing From Whole-Pelvic Radiation Therapy (WPRT) Alone to Vaginal Brachytherapy (VB) in the Adjuvant Setting for Endometrial Cancer: A SEER-Based Analysis From Years 2000-2011. Oncology (Williston Park). 2015;29(4)
(2015). (P077) Defining the Pendulum Swing From Whole-Pelvic Radiation Therapy (WPRT) Alone to Vaginal Brachytherapy (VB) in the Adjuvant Setting for Endometrial Cancer: A SEER-Based Analysis From Years 2000-2011. Oncology (Williston Park, N.Y.), 29(4), .
"(P077) Defining the Pendulum Swing From Whole-Pelvic Radiation Therapy (WPRT) Alone to Vaginal Brachytherapy (VB) in the Adjuvant Setting for Endometrial Cancer: A SEER-Based Analysis From Years 2000-2011." Oncology (Williston Park, N.Y.) vol. 29,4 (2015).
(P077) Defining the Pendulum Swing From Whole-Pelvic Radiation Therapy (WPRT) Alone to Vaginal Brachytherapy (VB) in the Adjuvant Setting for Endometrial Cancer: A SEER-Based Analysis From Years 2000-2011. Oncology (Williston Park). 2015 Apr 21;29(4). PMID: 25930848.
Copy Download .nbib Format: NLM
(P076) postoperative treatment recommendations for stage I endometrial cancer: a survey of society of gynecologic oncology members.

Oncology (Williston Park, N.Y.)

[No authors listed]
PMID: 25930847
Oncology (Williston Park). 2015 Apr 21;29(4).

No abstract available.

Cite
(P076) postoperative treatment recommendations for stage I endometrial cancer: a survey of society of gynecologic oncology members. Oncology (Williston Park). 2015;29(4)
(2015). (P076) postoperative treatment recommendations for stage I endometrial cancer: a survey of society of gynecologic oncology members. Oncology (Williston Park, N.Y.), 29(4), .
"(P076) postoperative treatment recommendations for stage I endometrial cancer: a survey of society of gynecologic oncology members." Oncology (Williston Park, N.Y.) vol. 29,4 (2015).
(P076) postoperative treatment recommendations for stage I endometrial cancer: a survey of society of gynecologic oncology members. Oncology (Williston Park). 2015 Apr 21;29(4). PMID: 25930847.
Copy Download .nbib Format: NLM
(S022) Experimental Insight Into the Preferential Cytotoxicity of Cancerous vs Noncancerous Cells of Metformin.

Oncology (Williston Park, N.Y.)

[No authors listed]
PMID: 25930761
Oncology (Williston Park). 2015 Apr 21;29(4).

No abstract available.

Cite
(S022) Experimental Insight Into the Preferential Cytotoxicity of Cancerous vs Noncancerous Cells of Metformin. Oncology (Williston Park). 2015;29(4)
(2015). (S022) Experimental Insight Into the Preferential Cytotoxicity of Cancerous vs Noncancerous Cells of Metformin. Oncology (Williston Park, N.Y.), 29(4), .
"(S022) Experimental Insight Into the Preferential Cytotoxicity of Cancerous vs Noncancerous Cells of Metformin." Oncology (Williston Park, N.Y.) vol. 29,4 (2015).
(S022) Experimental Insight Into the Preferential Cytotoxicity of Cancerous vs Noncancerous Cells of Metformin. Oncology (Williston Park). 2015 Apr 21;29(4). PMID: 25930761.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 487 entries